BLADDER CANCER AND DEBATE ON TRIMODAL THERAPY (TMT) FOR BLADDER PRESERVATION

Conteúdo do artigo principal

Antonio Marlos Duarte de Melo
José Angelo Araújo Sampaio
Ana Beatriz Callou Sampaio Neves
Isabella Callou Sampaio Neves
Lucas Leimig Telles Parente
Maria Valéria Leimig Telles
Mikael Vieira da Silva

Resumo

Abstract: Bladder Cancer is one of the most common types of malignant neoplasms that affects both men and women. The surgery considered standard for the treatment of invasive tumor is Radical Cystectomy, which causes undesirable morbidity in the postoperative period on affected patients. Radical Transurethral Resection (TRU), associated with Chemotherapy and Radiotherapy, together form the Trimodal Therapy (TTM), which can demonstrate satisfactory results in the approach of the patient with invasive tumor with lower morbidity and well-timed survival rate, in a short time.

 

Keywords: Bladder Cancer; Radical Cystectomy; Transurethral Resection; Trimodal Therapy.

Métricas

Carregando Métricas ...

Detalhes do artigo

Como Citar
Melo, A. M. D. de, Sampaio, J. A. A., Neves, A. B. C. S., Neves, I. C. S., Parente, L. L. T., Telles, M. V. L., & Silva, M. V. da. (2018). BLADDER CANCER AND DEBATE ON TRIMODAL THERAPY (TMT) FOR BLADDER PRESERVATION. Amadeus International Multidisciplinary Journal, 2(4), 52–56. https://doi.org/10.14295/aimj.v2i4.30
Seção
Article
Biografia do Autor

Antonio Marlos Duarte de Melo, Federal University of Ceará, Brasil

Professora Adjunta.

Referências

References

Jacobs, B., Lee, C. and Montie, J. (2010). Bladder Cancer in 2010: How Far have We Come?.CA: A Cancer Journal for Clinicians, 60(4), pp.244-272.

James, N., Hussain, S., Hall, E., Jenkins, P., Tremlett, J., Rawlings, C., Crundwell, M., Sizer, B.,Sreenivasan, T.,Hendron, C., Lewis, R., Waters, R. and Huddart, R. (2012). Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer. New England Journal of Medicine, 366(16), pp.1477-1488.

Premo, C., Apolo, A., Agarwal, P. and Citrin, D. (2015). Trimodality Therapy in Bladder Cancer. Urologic Clinics of North America, 42(2), pp.169-180.

Ploussard, G., Daneshmand, S., Efstathiou, J., Herr, H., James, N., Rödel, C., Shariat, S., Shipley, W., Sternberg, C., Thalmann, G. and Kassouf, W. (2014). Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review. European Urology, 66(1), pp.120-137.

Gakis, G., Efstathiou, J., Lerner, S., Cookson, M., Keegan, K., Guru, K., Shipley, W., Heidenreich, A., Schoenberg, M., Sagaloswky, A., Soloway, M. and Stenzl, A. (2013). ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder. European Urology, 63(1), pp.45-57.

Kulkarni, G., Hermanns, T., Wei, Y., Bhindi, B., Satkunasivam, R., Athanasopoulos, P., Bostrom, P., Kuk, C., Li, K., Templeton, A., Sridhar, S., van der Kwast, T., Chung, P., Bristow, R., Milosevic, M., Warde, P., Fleshner, N., Jewett, M., Bashir, S. and Zlotta, A. (2017). Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic. Journal of Clinical Oncology, pp.JCO.2016.69.232.

Mitin, T. (2017). Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? Opinion: No. International brazjurol, 43(2), pp.188-191.

Solsona, E., Iborra, I., Collado, A., Rubio-Briones, J., Casanova, J. And Calatrava, A. (2010). Feasibility of Radical Transurethral Resection as Monotherapy for Selected Patients With Muscle Invasive Bladder Cancer. The Journal of Urology, 184(2), pp.475-481.